rss
Br J Ophthalmol 2002;86:363 doi:10.1136/bjo.86.4.363-a
  • BJO at a glance

BJO at a glance

  1. Creig Hoyt, Editor

      WHAT DO WE DO ABOUT DIABETES?

      Despite improvements in the medical management of patients with diabetes, as well as improved surgical and laser techniques to treat diabetic retinopathy, visual loss related to diabetes remains a major healthcare problem. Understanding the mechanism of diabetic retinopathy may be important in order to develop new treatments. Adamis outlines the case for diabetic retinopathy having a prominent inflammatory component. He cautions that much work is yet to be done but makes a strong case for inflammation playing a major part in the vast changes related to diabetes. Anti-inflammatory drug testing in human diabetic retinopathy is already under way.

      Klein and Klein detail the case for more careful management of hypertension associated with diabetes: 30% of younger patients with diabetes and …

      [Full text of this article]

      This Article

      1. Extract
      2. Full text
      3. PDF

      Responses

      1. Submit a response
      2. No responses published

      Social bookmarking

      Register for free content


      Free sample
       This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
      View free sample issue >>

      Free archive
      The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.